1. Home
  2. REAX vs NRIX Comparison

REAX vs NRIX Comparison

Compare REAX & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REAX
  • NRIX
  • Stock Information
  • Founded
  • REAX 2018
  • NRIX 2009
  • Country
  • REAX United States
  • NRIX United States
  • Employees
  • REAX N/A
  • NRIX N/A
  • Industry
  • REAX
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • REAX
  • NRIX Health Care
  • Exchange
  • REAX Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • REAX 909.7M
  • NRIX 1.1B
  • IPO Year
  • REAX N/A
  • NRIX 2020
  • Fundamental
  • Price
  • REAX $4.12
  • NRIX $10.47
  • Analyst Decision
  • REAX Strong Buy
  • NRIX Strong Buy
  • Analyst Count
  • REAX 2
  • NRIX 17
  • Target Price
  • REAX $6.00
  • NRIX $30.82
  • AVG Volume (30 Days)
  • REAX 874.4K
  • NRIX 1.0M
  • Earning Date
  • REAX 03-06-2025
  • NRIX 04-14-2025
  • Dividend Yield
  • REAX N/A
  • NRIX N/A
  • EPS Growth
  • REAX N/A
  • NRIX N/A
  • EPS
  • REAX N/A
  • NRIX N/A
  • Revenue
  • REAX $1,264,639,000.00
  • NRIX $54,549,000.00
  • Revenue This Year
  • REAX $26.91
  • NRIX N/A
  • Revenue Next Year
  • REAX $19.13
  • NRIX $3.20
  • P/E Ratio
  • REAX N/A
  • NRIX N/A
  • Revenue Growth
  • REAX 83.50
  • NRIX N/A
  • 52 Week Low
  • REAX $3.02
  • NRIX $10.37
  • 52 Week High
  • REAX $6.75
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • REAX 36.60
  • NRIX 23.27
  • Support Level
  • REAX $3.97
  • NRIX $12.20
  • Resistance Level
  • REAX $4.66
  • NRIX $13.10
  • Average True Range (ATR)
  • REAX 0.19
  • NRIX 0.82
  • MACD
  • REAX -0.02
  • NRIX -0.10
  • Stochastic Oscillator
  • REAX 21.90
  • NRIX 2.33

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: